22,500
Participants
Start Date
August 25, 2021
Primary Completion Date
February 8, 2022
Study Completion Date
June 14, 2023
Recombinant SARS-CoV-2 fusion protein vaccine (V-01)
"Appearance: creamy white suspension Dosage form: Suspension for injection Strength: 10 μg (0.5mL) /vial Vaccination route: intramuscular injection into the lateral deltoid of the upper arm Vaccination dosage: 10 μg Immunization schedule: two doses, one each on Day 0 and 21 (+7 days), respectively.~Storage condition: store at 2\~8°C protected from light Expiry date: 24 months after production date"
Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
The dosage, appearance, administration method, and other aspects are consistent with that of investigational vaccine, except that no vaccine antigen is contained.
University of the Philippines - Philippine General Hospital, Manila
Far Eastern University-Nicanor Reyes Medical Foundation Medical Center, Quezon City
Mary Mediatrix Medical Center, Lipa City
The Medical City- Iloilo, Iloilo City
Andalas University Hospital, Padang
Medical Faculty of Mulawarman University, Samarinda
Medical Faculty of Padjadjaran University, Sumedang
Medical Faculty of UIN Syarif Hidayatullah, Tangerang
Makati Medical Center, Makati City
East Avenue Medical Center, Manila
Lung Center of the Philippines, Manila
Mary Chiles General Hospital, Manila
St. Luke's Medical Foundation Medical Center, Quezon City
Central Clinical Hospital of the Russian Academy of Sciences, Engel's
Oris LLC, Moscow
Zvezdnaya Clinic, Moscow
UZI-4D Clinic LLC, Pyatigorsk
Institute of Medical Research LLC, Saint Petersburg
Lab. of molecular virology Smorodintsev Research Institute of Influenza MoH, Saint Petersburg
"LLC Uromed", Saint Petersburg
Medical Technologies, Saint Petersburg
N.P. Bechtereva Institute of the Human Brain of the Russian Academy of Sciences, Saint Petersburg
Research Center ECO Safety LLC, Saint Petersburg
"State Budgetary Healthcare Institution Nikolaevskaya hospital", Saint Petersburg
Strategic Medical Systems LLC, Saint Petersburg
Lead Sponsor
Livzon Pharmaceutical Group Inc.
INDUSTRY